PROPRIETARY DELIVERY SYSTEM

NEUROTRANSMITTER PRODUCTION SUPPORT "N.P.S.™"

Intense exercise, stress, injuries, illness, and aging all can deplete the body of vital chemicals known as neurotransmitters.  Neurotransmitters are chemical "messenger" molecules that control the functioning of every part of the body.  Insufficient levels of various neurotransmitters can impair the functioning of the musculoskeletal system, cardiovascular system, reproductive system, and all other vital body systems.

Numerous pharmaceuticals stimulate the release of neurotransmitters or act to block their breakdown, but are unable to increase the amount of the neurotransmitter that the body produces.  Thus, pharmaceuticals are unable to correct the underlying deficiency of neurotransmitters that is frequently the cause of decreased performance or ill health.

Neurotransmitters can only be formed in the body from a select number of amino acids and other nutrients.  Additionally, in order for neurotransmitters to be produced, certain nerve cells must be activated.  Unless these nerve cells are activated, simply supplying nutrients is insufficient to increase production of neurotransmitters.

The key to increasing the amount of the neurotransmitter produced by the body is to supply the needed nutrients while simultaneouslyactivating the nerve cells that produce the desired neurotransmitter.  This concept forms the basis of the proprietary formulation strategy known as N.P.S.™ that Total Health utilizes to create its line of products.  Total Health is targeting the production of nitric oxide when activating the desired neurotransmitter. 

N.P.S.™ is designed to achieve synergistic effects by combining neurotransmitter precursors with ingredients that promote neurotransmitter release.  The body keeps nerve cells “turned off” (inhibited from firing) until they are needed, to prevent neurotransmitters from continually being released.

In order for a neurotransmitter to be synthesized, two things need to happen.  First, the nutrient the neurotransmitter is composed of (its precursor) must be available.  Second, a neuron must be releasing a neurotransmitter in order to initiate neurotransmitter production.  Triggering release of a neurotransmitter activates cellular intake of its precursor in order to replenish what was released by increasing neurotransmitter synthesis. 

To illustrate the N.P.S.™ concept, imagine a factory.  In order for a factory to convert raw materials into a finished product, the assembly line must be turned on.  If the assembly line remains inactive, the raw materials will not be converted into the finished product.  N.P.S.™-based products are designed to "turn on" cells that change the "raw materials" into neurotransmitters.

Previously, administering large quantities of neurotransmitter precursors has failed to produce significant increases in neurotransmitter synthesis.  This is similar to delivering massive amounts of raw materials to a factory's loading dock and having them remain unused because the assembly line was not turned on.  N.P.S.™ is designed to increase the amount of a neurotransmitter produced by supplying a neurotransmitter precursor and simultaneously promoting neuron firing.

N.P.S.™ addresses the crucial components that are essential for neurotransmitter synthesis to occur.  N.P.S.™ targets the same process the body uses to activate neurotransmitter synthesis, allowing N.P.S.™ to significantly increase neurotransmitter synthesis using minimal amounts of the individual agents.

Targeting each of the crucial mechanisms needed to activate synthesis of a neurotransmitter is similar to opening a door locked with a combination lock.  By entering the correct combination, the locked door opens easily.  Attempting to promote synthesis of a neurotransmitter by administering multi-gram quantities of its precursor can be likened to opening the door by using a bulldozer.

N.P.S.™-based products are formulated to normalize body functions.  These products are not designed to stimulate or inhibit mechanisms within the body, as with drugs.  Drugs can produce undesirable effects in a healthy animal by inhibiting or stimulating mechanisms beyond the normal range.  Products based on N.P.S.™ principles are designed to only restore under-functioning mechanisms to within the normal range.  This results in N.P.S.-based products having a tremendously greater margin of safety as compared to pharmaceuticals.